共 17 条
Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models
被引:211
作者:
Flies, Dallas B.
[1
]
Wang, Shengdian
[2
]
Xu, Haiying
[3
]
Chen, Lieping
[1
,4
]
机构:
[1] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA
[2] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100190, Peoples R China
[3] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[4] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06519 USA
基金:
美国国家卫生研究院;
关键词:
CELL-ACTIVATION;
LYMPHOCYTE;
ANTIGEN;
PATHWAY;
PD-1;
D O I:
10.4049/jimmunol.1100660
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Upon interaction with B7 homolog 1, programmed death-1 (PD-1) transmits a critical coinhibitory signal to T cells to negatively regulate immune responses. By extensively searching the genomic database with the IgV region of PD-1, we identified a homolog and named it PD-1 homolog (PD-1H). PD-1H is broadly expressed on the cell surface of hematopoietic cells and could be further upregulated on CD4(+) and CD8(+) T cells following activation. We have generated an mAb against PD-1H, which strikingly prevents acute graft-versus-host disease in semi-and fully allogeneic murine models, leading to full chimerism following treatment. Graft-versus-host disease remains a primary hindrance to successful allogeneic hematopoietic cell transplantation therapy for the treatment of hematologic malignancy. Therefore, manipulation of PD-1H function may provide a new modality for controlling T cell responses to allogeneic tissues in transplant medicine. The Journal of Immunology, 2011, 187: 1537-1541.
引用
收藏
页码:1537 / 1541
页数:5
相关论文